The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
- PMID: 8423785
- PMCID: PMC359003
- DOI: 10.1128/mcb.13.2.1183-1193.1993
The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
Abstract
Acute-phase reactants are liver proteins whose synthesis is positively or negatively regulated during inflammation. The main mediators of this phenomenon are glucocorticoids and interleukin-6 (IL-6), a pleiotropic cytokine that also controls hematopoiesis. Functional analysis of several acute-phase reactant promoter regions has identified two major DNA motifs used by IL-6-regulated genes. The first one corresponds to a CTGG(G/A)AA sequence, and the other is a binding site for members of the C/EBP family of nuclear proteins. We have previously shown that the human beta fibrinogen (beta Fg) promoter contains an IL-6-responsive region, located between bp -150 and -67 (P. Huber, M. Laurent, and J. Dalmon, J. Biol. Chem. 265:5695-5701, 1990). In this study, using DNase I footprinting, mobility shift assays, and mutagenesis, we demonstrate that at least three subdomains of this region are necessary to observe a full response to IL-6. The most distal contains a CTGGGAA motif, and its mutation inhibits IL-6 stimulation. Another, which is able to interact with several distinct nuclear proteins, among them members of the C/EBP family, is dispensable for IL-6 induction but plays an important role in the constitutive expression of beta Fg. Finally, a proximal hepatocyte nuclear factor 1 binding site, already described as the major determinant of beta Fg tissue-specific expression, is also required for IL-6 stimulation. These results indicate a complex interplay between nuclear proteins within the beta Fg IL-6-responsive region and suggest a tight functional coupling between the tissue-specific and inducible elements.
Similar articles
-
Characterization of the 5'-flanking region of the gene for the alpha chain of human fibrinogen.J Biol Chem. 1995 Nov 24;270(47):28342-9. doi: 10.1074/jbc.270.47.28342. J Biol Chem. 1995. PMID: 7499335
-
Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.Mol Cell Biol. 2001 Jan;21(2):414-24. doi: 10.1128/MCB.21.2.414-424.2001. Mol Cell Biol. 2001. PMID: 11134330 Free PMC article.
-
Transcriptional regulation of the Xenopus laevis B beta fibrinogen subunit gene by glucocorticoids and hepatocyte nuclear factor 1: analysis by transfection into primary liver cells.Biochemistry. 1993 Nov 2;32(43):11627-37. doi: 10.1021/bi00094a020. Biochemistry. 1993. PMID: 8218230
-
Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6REs.J Biol Chem. 2003 Oct 17;278(42):41270-81. doi: 10.1074/jbc.M304210200. Epub 2003 Aug 4. J Biol Chem. 2003. PMID: 12900415
-
A novel DNA/protein complex interacts with the insulin-like growth factor binding protein-1 (IGFBP-1) insulin response sequence and is required for maximal effects of insulin and glucocorticoids on promoter function.Prog Growth Factor Res. 1995;6(2-4):119-29. doi: 10.1016/0955-2235(95)00020-8. Prog Growth Factor Res. 1995. PMID: 8817653 Review.
Cited by
-
Regulation of fibrinogen synthesis.Thromb Res. 2024 Oct;242:109134. doi: 10.1016/j.thromres.2024.109134. Epub 2024 Aug 28. Thromb Res. 2024. PMID: 39216273 Review.
-
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.Mol Cell Biol. 2001 Mar;21(5):1621-32. doi: 10.1128/MCB.21.5.1621-1632.2001. Mol Cell Biol. 2001. PMID: 11238899 Free PMC article.
-
Curcuma longa extract improves serum inflammatory markers and mental health in healthy participants who are overweight: a randomized, double-blind, placebo-controlled trial.Nutr J. 2021 Nov 13;20(1):91. doi: 10.1186/s12937-021-00748-8. Nutr J. 2021. PMID: 34774052 Free PMC article. Clinical Trial.
-
Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins.Cell Genom. 2023 May 30;3(7):100339. doi: 10.1016/j.xgen.2023.100339. eCollection 2023 Jul 12. Cell Genom. 2023. PMID: 37492105 Free PMC article.
-
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.J Clin Pathol. 2006 Feb;59(2):211-5. doi: 10.1136/jcp.2004.025452. J Clin Pathol. 2006. PMID: 16443741 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources